We found that treating SPC-A-1 cells with MG132, a ubiquitination–proteasome inhibitor, increased SAV1 levels and that lycorine treatment further increased SAV1 protein levels in cancer cells in the presence of MG132 (Fig. 3e, f). The gene discussed is SAV1; the disease is cancer.